Transcription factors in myeloid development: balancing differentiation with transformation
The DOI matches its Crossref record; 141 of the 142 references it cites were found in a registry or an index.
Abstract
In recent years, great progress has been made in elucidating the progenitor-cell hierarchy of the myeloid lineage. Transcription factors have been shown to be key determinants in the orchestration of myeloid identity and differentiation fates. Most transcription factors show cell-lineage-restricted and stage-restricted expression patterns, indicating the requirement for tight regulation of their activities. Moreover, if dysregulated or mutated, these transcription factors cause the differentiation block observed in many myeloid leukaemias. Consequently, therapies designed to restore defective transcription factor functions are an attractive option in the treatment of myeloid and other human cancers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, downregulation of PU.1 was identified as a mechanism for the induction of leukemias generated by PML-RARa, FLT3-ITD, and AML1-ETO.[43][44][45]”
From USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism (2018) · cites this paper as [43]
In the citing paper
“PU.1, a non-canonical pioneer transcription factor that functions as a master regulator of myeloid and lymphoid lineage differentiation18–20.”
From Lymphoid gene expression supports neuroprotective microglia function (2025) · cites this paper as [18]
In the citing paper
“Irf8 promotes GM lineage differentiation.”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [29]
In the citing paper
“In particular, Irf8 promotes monocyte differentiation as a lineage switch between monocyte and granulocyte bifurcation29.”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [29]
In the citing paper
“All activated macrophages, regardless of polarization state, express high levels of the transcription factors runt-related transcription factor 1 (RUNX1) and PU.1, which are thought to represent global regulators of macrophage phenotypic expression [20–22].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [20]
Citations
Cites
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617 · cited 1×
“The first lymphoid progenitor population that is known to arise from MPPs is the common lymphoid progenitors (CLPs; LIN − IL-7Rα + SCA1 low KIT low”
BackgroundIdentification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
Differentiation and proliferation of hematopoietic stem cells
Ogawa, M. (1993) · Blood · doi:10.1182/blood.v81.11.2844.2844 · Cited by 1,383
Identification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic Potential
Adolfsson, J., Månsson, R., Buza-Vidas, N., Hultquist, A., Liuba, K., Jensen, C. T., Bryder, D., Yang, L., Borge, O.-J., Thoren, L. A. M., et al. (2005) · Cell · doi:10.1016/j.cell.2005.02.013 · Cited by 1,236
Oncogenic Transcription Factors in the Human Acute Leukemias
Look, A. T. (1997) · Science · doi:10.1126/science.278.5340.1059 · Cited by 1,187
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130
A Clonogenic Bone Marrow Progenitor Specific for Macrophages and Dendritic Cells
Fogg, D. K., Sibon, C., Miled, C., Jung, S., Aucouturier, P., Littman, D. R., Cumano, A., & Geissmann, F. (2006) · Science · doi:10.1126/science.1117729 · Cited by 1,053
Research works printed but not linked: 1
- Iwasaki, H. et al. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 106, 1590–1600 (2005). · DOI · Paper page
Cited by
Items 201–300 of 608
MicroRNA-10a/b are regulators of myeloid differentiation and acute myeloid leukemia
Bi, L., Sun, L., Jin, Z., Zhang, S., & Shen, Z. (2018) · Oncology Letters · doi:10.3892/ol.2018.8050 · Cited by 50
“…transcriptional factors (PU.1, CCAAT/enhancer-binding protein α , interferon regulatory factor 8, TAL bHLH transcription factor 1 and runt-related transcription factor 1) (11), cytokines [granulocyte colony-stimulating factor (CSF), macrophage-CSF and interleukin-3] (12) and non-coding RNAs (13).”
Acetylation of C/EBPε is a prerequisite for terminal neutrophil differentiation
Bartels, M., Govers, A. M. A. P., Fleskens, V., Lourenço, A. R., Pals, C. E. G. M., Vervoort, S. J., van Gent, R., Brenkman, A. B., Bierings, M., Ackerman, S. J., et al. (2015) · Blood · doi:10.1182/blood-2013-12-543850 · Cited by 51
“1, CCAATdisplacement protein (CDP), the retinoic acid receptor (RAR), and C/EBPe.(9,42,43) Studies in C/EBPe-deficient mice have demonstrated that this transcription factor is indispensible for neutrophilmaturation and function.”
InfluentialHochweller, K., Miloud, T., Striegler, J., Naik, S. H., Hämmerling, G. J., & Garbi, N. (2009) · Blood · doi:10.1182/blood-2008-11-188045 · Cited by 51
RNA N 6-Methyladenosine Modification in Normal and Malignant Hematopoiesis
Weng, H., Huang, H., & Chen, J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7342-8_4 · Cited by 53
Walsh, S. R., Linnerth-Petrik, N. M., Laporte, A. N., MENZIES, P. I., Foster, R. A., & Wootton, S. K. (2010) · Virus Research · doi:10.1016/j.virusres.2010.04.002 · Cited by 49
Dual negative roles of C/EBPα in the expansion and pro-tumor functions of MDSCs
Mackert, J. R., Qu, P., Min, Y., Johnson, P. F., Li, Y., & Lin, P. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-12968-2 · Cited by 45
Yang, L., Jiang, Y., Wu, S.-F., Zhou, M., Wu, Y. L., & Chen, G. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm262 · Cited by 45
“Multiple important hematopoiesisrelated transcription factors such as C/EBPa, Runt-related protein 1 (Runx1, also called as acute myeloid leukemia 1, AML1) and PU.1 ( 33 ) synergistically regulate the differentiation of immature progenitors in bone marrow to terminally differentiated/mature cells in peripheral blood (…”
BackgroundNextPBM: a platform to study cell-specific transcription factor binding and cooperativity
Mohaghegh, N., Bray, D., Keenan, J. L., Penvose, A. R., Andrilenas, K. K., Ramlall, V., & Siggers, T. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz020 · Cited by 66
Myeloid cell diversification and complexity: an old concept with new turns in oncology
Chioda, M., Peranzoni, E., Desantis, G., Papalini, F., Falisi, E., Solito, S., Mandruzzato, S., & Bronte, V. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9268-1 · Cited by 47
“The C/EBP family comprises different transcription factors that regulate myeloid differentiation and function: their differential expression is tightly controlled during macrophage and granulocyte differentiation [92].”
BackgroundMorris, V., Cummings, C. L., Korb, B., Boaglio, S. M., & Oehler, V. G. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00712-15 · Cited by 46
A microglial hypothesis of globoid cell leukodystrophy pathology
Nicaise, A. M., Bongarzone, E. R., & Crocker, S. J. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23773 · Cited by 46
Radandish, M., Khalilian, P., & Esmaeil, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.667705 · Cited by 43
Tsiftsoglou, A. S., Bonovolias, I. D., & Tsiftsoglou, S. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.03.001 · Cited by 50
“…of chimeric fusion protein (e.g. Bcr-Abl chimeric tyrosine kinase, PML/ RARa, AML1/ETO and AML1/RUNX1) impairs the normal hematopoiesis and promotes hematological malignancies (Erickson et al., 1992; Rabbitts, 1994; Salesse & Verfaillie, 2003; Asou, 2003; Brady, 2003; Rosenbauer & Tenen, 2007).”
BackgroundMMP3-Mediated tumor progression is controlled transcriptionally by a novel IRF8-MMP3 interaction
Banik, D., Netherby, C. S., Bogner, P. N., & Abrams, S. I. (2015) · Oncotarget · doi:10.18632/oncotarget.3897 · Cited by 43
“While IRF8 is recognized as a tumor suppressor gene in certain hematopoietic malignancies [7–13], in solid tumor models, these additional studies [2, 3, 15, 18–20] underscore previously unrecognized anti-neoplastic activities for IRF8 perhaps distinct from its tumor suppressor roles.”
BackgroundThe epigenome of AML stem and progenitor cells
Yamazaki, J., Estecio, M. R., Lu, Y., Long, H., Malouf, G. G., Graber, D., Huo, Y., Ramagli, L., Liang, S., Kornblau, S. M., et al. (2013) · Epigenetics · doi:10.4161/epi.23243 · Cited by 41
Regulation of chromatin accessibility by the histone chaperone CAF-1 sustains lineage fidelity
Franklin, R., Guo, Y., He, S., Chen, M., Ji, F., Zhou, X., Frankhouser, D. E., Do, B. T., Chiem, C., Jang, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29730-6 · Cited by 46
The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1
Jenal, M., Batliner, J., Reddy, V. A., Haferlach, T., Tobler, A., Fey, M. F., Torbett, B. E., & Tschan, M. P. (2010) · Leukemia · doi:10.1038/leu.2010.26 · Cited by 44
Metal complexes as inhibitors of transcription factor activity
Leung, C., He, H., Liu, L., Wang, M., Chan, D. S., & Ma, D. (2013) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2013.08.008 · Cited by 41
Behrens, K., Triviai, I., Schwieger, M., Tekin, N. S., Alawi, M., Spohn, M., Indenbirken, D., Ziegler, M., Müller, U., Alexander, W. S., et al. (2016) · Blood · doi:10.1182/blood-2015-09-668129 · Cited by 45
Regulation of Adult Hematopoietic Stem Cells Fate for Enhanced Tissue-specific Repair
Sengupta, N., Caballero, S., Sullivan, S. M., Chang, L.-J., Afzal, A., Calzi, S. L., Kielczewski, J. L., Prabarakan, S., Ellis, E. A., Moldovan, L., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.145 · Cited by 40
Deng, K., Li, C., Huang, H., & Li, X. (2016) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2016.09.107 · Cited by 39
Bivalent Histone Codes on WNT5A during Odontogenic Differentiation
Zhou, X., Zheng, L., Li, F., Wan, M., Fan, Y., Zhou, X., Du, W. T., Pi, C., Cui, D., Zhang, B., et al. (2017) · Journal of Dental Research · doi:10.1177/0022034517728910 · Cited by 38
Alterations of specific chromatin conformation affect ATRA-induced leukemia cell differentiation
Li, Y., He, Y., Liang, Z., Wang, Y., Chen, F., Djekidel, M. N., Li, G., Zhang, X., Xiang, S., Wang, Z., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0173-6 · Cited by 46
The Polycomb-associated factor PHF19 controls hematopoietic stem cell state and differentiation
Vizán, P., Gutiérrez, A., Espejo, I., García-Montolio, M., Lange, M., Carretero, A., Lafzi, A., de Andrés-Aguayo, L., Blanco, E., Thambyrajah, R., et al. (2020) · Science Advances · doi:10.1126/sciadv.abb2745 · Cited by 41
“Increased H3K27me3 deposition in lineage-specific transcription factors could be observed for essential genes—such as Cebpa (for myeloid) (33); Pax5 and Irf5 (for B cells) (34, 35); Tcf7 (for T cells) (36); several members of Notch pathway [Dll1 (depicted), Dll4, Jag2, or Hes1], which are well-known regulators of both…”
BackgroundThe Essential Transcriptional Function of BRD4 in Acute Myeloid Leukemia
Roe, J., & Vakoc, C. R. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.031039 · Cited by 46
Katzerke, C., Madan, V., Gerloff, D., Bräuer-Hartmann, D., Hartmann, J.-U., Wurm, A. A., Müller-Tidow, C., Schnittger, S., Tenen, D. G., Niederwieser, D., et al. (2013) · Blood · doi:10.1182/blood-2012-12-472183 · Cited by 38
Self-citationBuechler, M. B., Akilesh, H. M., & Hamerman, J. A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600813 · Cited by 42
“Concomitantly, TLR7 signaling altered the expression of myeloid-differentiation associated genes (18) within 48 h.”
BackgroundMicroRNA Profiling in Human Neutrophils during Bone Marrow Granulopoiesis and In Vivo Exudation
Larsen, M. T., Hother, C. E., Häger, M., Pedersen, C. C., Theilgaard‐Mönch, K., Borregaard, N., & Cowland, J. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058454 · Cited by 42
“The regulation of C/EBP-e expression is not yet elucidated, but the miRNAs in cluster 3 could possibly be regulated by the same mechanism(s).”
BackgroundInfluentialUnfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia
Schardt, J., Eyholzer, M., Timchenko, N. A., Mueller, B. U., & Pabst, T. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00870.x · Cited by 41
Ye, B., Liu, B., Yang, L., Huang, G., Hao, L., Xia, P., Wang, S., Du, Y., Qin, X. S., Zhu, P., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01788-7 · Cited by 41
Extramedullary hematopoiesis in cancer
Barisas, D. A. G., & Choi, K. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01192-4 · Cited by 51
“The development of myeloid cells involves a complex balance of select transcription factors throughout the differentiation process 29 .”
BackgroundmiR‐155expression in antitumor immunity: The higher the better?
Michaille, J., Awad, H., Fortman, E. C., Efanov, A. A., & Tili, E. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22698 · Cited by 43
Mechanisms of myeloid leukemogenesis: Current perspectives and therapeutic objectives
Bouligny, I. M., Maher, K. R., & Grant, S. (2022) · Blood Reviews · doi:10.1016/j.blre.2022.100996 · Cited by 47
“Functional CEBP α directly interacts with coactivators and repressors dependent on cell type and allows progression from the myeloblast to granulocytemacrophage progenitors [113].”
BackgroundPLCγ2 and PKC Are Important to Myeloid Lineage Commitment Triggered by M‐SCF and G‐CSF
Barbosa, C. M. V., Bincoletto, C., Barros, C. C., Ferreira, A. T., & Paredes‐Gamero, E. J. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24653 · Cited by 37
Iosue, I., Quaranta, R., Masciarelli, S., Fontemaggi, G., Batassa, E. M., Bertolami, C., Ottone, T., Divona, M., Salvatori, B., Padula, F., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.452 · Cited by 40
“which cooperatively regulate the activity of promoters and enhancers present on their target genes.(1) Recent findings, however, indicate that microRNAs (miRNAs) also affect”
BackgroundC/EBPα is required for development of dendritic cell progenitors
Welner, R. S., Bararia, D., Amabile, G., Czibere, A. G., Benoukraf, T., Bach, C., Wansa, K. D. S. A., Ye, M., Zhang, H., Iino, T., et al. (2013) · Blood · doi:10.1182/blood-2012-10-463448 · Cited by 41
Self-citationIdentification of nuclear-enriched miRNAs during mouse granulopoiesis
Wong, J. J. L., Ritchie, W., Gao, D., Lau, K. A., Gonzalez, M., Choudhary, A., Taft, R. J., Rasko, J. E. J., & Holst, J. (2014) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-7-42 · Cited by 41
“This process is tightly controlled by changes in the expression of hundreds of transcription factors [12,13], which are in turn regulated by a few highly expressed miRNAs, including miR-223 and miR-146a, both of which have been shown to promote granulopoiesis [14-16].”
Gemelli, C., Zanocco‐Marani, T., Bicciato, S., Mazza, E. M. C., Boraschi, D., Salsi, V., Zappavigna, V., Parenti, S., Selmi, T., Tagliafico, E., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.01.021 · Cited by 36
“played by transcriptional regulation in the monocyte maturation program, demonstrating the combinatorial action and the regulatory interdependence of a considerable number of myeloid TFs, belonging to a limited set of protein families (MAF, Mitf-Tfe, HOX, PPAR, C/EBP, IRF, EGR) [2-8].”
BackgroundCEBPA-dependent HK3 and KLF5 expression in primary AML and during AML differentiation
Federzoni, E. A., Humbert, M., Torbett, B. E., Behre, G., Fey, M. F., & Tschan, M. P. (2014) · Scientific Reports · doi:10.1038/srep04261 · Cited by 38
Skokowa, J., Fobiwe, J. P., Lan, D., Thakur, B. K., & Welte, K. (2009) · Blood · doi:10.1182/blood-2008-11-188755 · Cited by 37
Molecular mechanisms underlying deregulation of C/EBPα in acute myeloid leukemia
Reckzeh, K., & Cammenga, J. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0573-1 · Cited by 43
“The two fundamental features of AML include a block of differentiation caused by reduced function of transcription factors that are specifically important for terminal differentiation of one or more myeloid lineages, and subsequently deregulated proliferation and cell survival by activation of oncogenes or deactivatio…”
BackgroundBloodExpress: a database of gene expression in mouse haematopoiesis
Miranda‐Saavedra, D., De, S., Trotter, M. W. B., Teichmann, S. A., & Göttgens, B. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn854 · Cited by 34
Croker, B. A., Mielke, L. A., Wormald, S., Metcalf, D., Kiu, H., Alexander, W. S., Hilton, D. J., & Roberts, A. W. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.02.008 · Cited by 34
Pal, P., Lochab, S., Kanaujiya, J. K., Kapoor, I., Sanyal, S., Behre, G., & Trivedi, A. K. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.120 · Cited by 38
“Notably, loss of function or expression of C/EBPa provides a platform for acute myeloid leukemia (AML) development.(9) C/EBPa is mutated in B9% of AML cases; reported mutations in C/EBPa comprise point mutations in basic leucine-zipper domain or N-terminus frame-shift mutations leading to formation of a dominant negat…”
BackgroundMasciarelli, S., Quaranta, R., Iosue, I., Colotti, G., Padula, F., Varchi, G., Fazi, F., & Río, A. D. (2014) · ACS Chemical Biology · doi:10.1021/cb500286b · Cited by 36
Transcriptomic profiling identifies a PU.1 regulatory network in macrophages
Weigelt, K., Lichtinger, M., Rehli, M., & Langmann, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.067 · Cited by 33
Heterozygous deletion of the PU.1 locus in human AML
Bonadies, N., Pabst, T., & Mueller, B. U. (2010) · Blood · doi:10.1182/blood-2009-03-212225 · Cited by 33
Keightley, M.-C., Carradice, D., Layton, J. E., Pase, L. B., Bertrand, J. Y., Wittig, J. G., Dakic, A., Badrock, A. P., Cole, N. J., Traver, D. J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14911 · Cited by 32
Jin, S., Su, H., Tran, N. T., Song, J., Lu, S. X., Li, Y., Huang, S., Abdel-Wahab, O. I., Liu, Y., & Zhao, X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175523 · Cited by 36
Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH network
Kingsbury, T. J., Kim, M.-J., & Civin, C. I. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2018.12.001 · Cited by 35
Ptasinska, A., Pickin, A., Assi, S. A., Chin, P. S., Ames, L., Avellino, R., Gröschel, S., Delwel, R., Cockerill, P. N., Osborne, C. S., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.040 · Cited by 39
“3022 Cell Reports 28, 3022–3031, September 17, 2019 a 2019 The A This is an open access article under the CC BY license (http://creative transcription factors (TFs) regulating hematopoiesis have to be expressed in a stage- and lineage-restricted fashion since their mutation or de-regulation impairs differentiation and…”
BackgroundInfluentialYang, Z.-F., Drumea, K. C., Cormier, J., Wang, J., Zhu, X., & Rosmarin, A. G. (2011) · Blood · doi:10.1182/blood-2010-07-298802 · Cited by 39
“2-expressing Gabpafl/fl-Mx1 Cre mice and (2) wild-type donors that express CD45.”
BackgroundMolecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model
Reckzeh, K., Bereshchenko, O., Mead, A. J., Rehn, M., Kharazi, S., Jacobsen, S. E. W., Nerlov, C., & Cammenga, J. (2012) · Leukemia · doi:10.1038/leu.2012.37 · Cited by 37
Lymphoid gene expression supports neuroprotective microglia function
Ayata, P., Crowley, J. M., Challman, M. F., Sahasrabuddhe, V., Gratuze, M., Werneburg, S., Ribeiro, D., Hays, E. C., Durán-Laforet, V., Faust, T. E., et al. (2025) · Nature · doi:10.1038/s41586-025-09662-z · Cited by 32
The metabolic regulator mTORC1 controls terminal myeloid differentiation
Lee, P. Y., Sykes, D. B., Ameri, S., Kalaitzidis, D., Charles, J. F., Nelson-Maney, N., Wei, K., Cunin, P., Morris, A., Cardona, A. E., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aam6641 · Cited by 36
Differential DNA Methylation Analysis without a Reference Genome
Klughammer, J., Datlinger, P., Printz, D., Sheffield, N. C., Farlik, M., Hadler, J., Fritsch, G., & Bock, C. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.024 · Cited by 34
“on Analysis without a”
C/EBPα: critical at the origin of leukemic transformation
Roe, J., & Vakoc, C. R. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20132530 · Cited by 35
“…transcriptional pathways feature prominently in the genetic etiology of AML, which can occur in the form of gain- or loss-of-function mutations in lineage-specific transcription factors, histone modifying enzymes, and DNA methylation machineries (Rosenbauer and Tenen, 2007; Shih et al., 2012).”
InfluentialThe role of microRNA in neuronal inflammation and survival in the post ischemic brain: a review
Li, W. A., Efendizade, A., & Ding, Y. (2017) · Neurological Research · doi:10.1080/01616412.2017.1327505 · Cited by 35
Regulation of the positive transcriptional effect of PLZF through a non-canonical EZH2 activity
Koubi, M., Poplineau, M., Vernerey, J., N’Guyen, L., Tibéri, G., Garciaz, S., Kaoutari, A. E., Maqbool, M. A., Andrau, J., Guillouf, C., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky080 · Cited by 33
“Transcription factors (TFs) have long been recognized as major regulators of blood stem cell development and the subsequent differentiation into multiple mature hematopoietic lineages (1).”
BackgroundMöröy, T., & Khandanpour, C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00824 · Cited by 39
Brief review on the roles of neutrophils in cancer development
Wang, L., Chen, J., Chen, G., Lin, Z., Xie, X., & Dai, H. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.4mr0820-011r · Cited by 36
Sasaki, Y., Guo, Y., Goto, T., Ubukawa, K., Asanuma, K., Kobayashi, I., Sawada, K., Wakui, H., & Takahashi, N. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100168 · Cited by 29
CellComm infers cellular crosstalk that drives haematopoietic stem and progenitor cell development
da Rocha, E. L., Kubaczka, C., Sugden, W. W., Najia, M. A. T., Jing, R., Markel, A., LeBlanc, Z. C., Peixoto, R. D. S., Falchetti, M., Collins, J. J., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00884-1 · Cited by 31
Skokowa, J., & Welte, K. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04963.x · Cited by 32
A distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemia
(2022) · doi:10.1101/gad.349284.121 · Cited by 31
Taskesen, E., Babaei, S., Reinders, M. M., & de Ridder, J. (2015) · BMC Bioinformatics · doi:10.1186/1471-2105-16-s4-s5 · Cited by 30
“double mutation in CEBPA) can cause a selective block in differentiation, a hallmark of AML [10,11].”
BackgroundTeixeira, A., Carreira, L., Abalde‐Cela, S., Sampaio‐Marques, B., Areias, A. C., Ludovico, P., & Diéguez, L. (2023) · Cancers · doi:10.3390/cancers15051362 · Cited by 42
“These abnormalities are usually associated with non-random chromosomal translocations that result in gene arrangements implicated in a modification in the locus encoding for a transcriptional activator, leading to the expression of a fusion protein [43].”
BackgroundClusterin drives myeloid bias in aged hematopoietic stem cells by regulating mitochondrial function
Sun, N., Lin, C.-H., Li, M. Y., Wang, Y., Chen, D., Ren, X., Zhang, F., & Zhang, Y. (2025) · Nature Aging · doi:10.1038/s43587-025-00908-z · Cited by 37
Genome-Wide Analysis of Transcriptional Reprogramming in Mouse Models of Acute Myeloid Leukaemia
Bonadies, N., Foster, S. D., Chan, W.-I., Kvinlaug, B. T., Spensberger, D., Dawson, M. A., Spooncer, E., Whetton, A. D., Bannister, A. J., Huntly, B. J. P., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016330 · Cited by 33
“Although, much has been learnt about the role of single transcription factors in both normal haematopoiesis and leukaemogenesis [16,17], only the recent advent of array- and sequencing-based high-throughput technologies has enabled functional investigations on a genome-wide scale.”
Zhang, J., Song, L., Huang, Y., Zhao, Q. L., Zhao, K.-W., & Chen, G. (2008) · Haematologica · doi:10.3324/haematol.13096 · Cited by 30
“Dysregulation and/or mutations of these factors have been found in many types of leukemia resulting in differentiation blockage.(12) These transcriptional factors also contribute to ATRA-induced differentiation of AML cells.”
BackgroundPak2 Regulates Hematopoietic Progenitor Cell Proliferation, Survival, and Differentiation
Zeng, Y., Broxmeyer, H. E., Staser, K. W., Chitteti, B. R., Park, S.-J., Hahn, S., Cooper, S. H., Sun, Z., Jiang, L., Yang, X., et al. (2015) · Stem Cells · doi:10.1002/stem.1951 · Cited by 31
Zhou, W., Li, S., Wang, H., Zhou, J., Li, S., Chen, G., Guan, W. P., Fu, X., Nervi, C., Yu, L., et al. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00480-z · Cited by 30
“PU.1 has been reported to strongly promote differentiation of myeloid lineages [43, 44], acting as a tumor suppressor gene in AML [45].”
BackgroundHuang, J., Zhou, Q. L., Huang, C.-H., Song, Y., Sharma, A. G., Liao, Z., Zhu, K. Y., Massidda, M. W., Jamieson, R., Zhang, J.-Y., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.c116.758748 · Cited by 32
“1 is known to be required for HSC differentiation to the myeloid lineage, and C/EBP / and GFI-1 are necessary for terminal differentiation of myeloid cells (13, 14).”
BackgroundSelf-citationAlbanesi, J., Noguera, N. I., Banella, C., Colangelo, T., Marinis, E. D., Leone, S., Palumbo, O., Voso, M. T., Ascenzi, P., Nervi, C., et al. (2020) · Cells · doi:10.3390/cells9112423 · Cited by 35
Kandilci, A., & Grosveld, G. C. (2009) · Blood · doi:10.1182/blood-2009-02-205443 · Cited by 28
“(3) Reintroduction of tamoxifen-inducible or -constitutive CEBPA bypassed these effects of MN1, suggesting that CEBPA repression contributes to the MN1-induced hematopoietic phenotype.”
InfluentialAn erythroid-to-myeloid cell fate conversion is elicited by LSD1 inactivation
Yu, L., Myers, G., Ku, C.-J., Schneider, E., Wang, Y., Singh, S. A., Jearawiriyapaisarn, N., White, A. D., Moriguchi, T., Khoriaty, R. N., et al. (2021) · Blood · doi:10.1182/blood.2021011682 · Cited by 33
Speicher, A. M., Korn, L., Csatári, J., Gonzalez-Cano, L., Heming, M., Thomas, C., Schroeter, C. B., Schafflick, D., Li, X., Gola, L., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2123476119 · Cited by 28
Herrera, M., Salva, S., Villena, J., Barbieri, N., Marranzino, G., & Alvarez, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090227 · Cited by 31
“that have the potential to produce all blood cell types and with a limited capacity for self-renewal [21] and in Common Myeloid”
BackgroundRole of UTX in Retinoic Acid Receptor-Mediated Gene Regulation in Leukemia
Rocha-Viegas, L., Villa, R., Gutiérrez, A., Iriondo, O., Shiekhattar, R., & Croce, L. D. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00839-14 · Cited by 28
Transcriptional mechanisms of cell fate decisions revealed by single cell expression profiling
Moignard, V., & Göttgens, B. (2014) · BioEssays · doi:10.1002/bies.201300102 · Cited by 33
Zhang, B., Zhang, Z., Koeken, V. A. C. M., Kumar, S., Aillaud, M., Tsay, H.-C., Liu, Z., Kraft, A. R. M., Soon, C. F., Odak, I., et al. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100232 · Cited by 28
“Schulte, Yang Li PII: S2666-979X(22)00190-2 DOI: https://doi.”
Katzenback, B. A., Katakura, F., & Belosevic, M. (2015) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2015.10.024 · Cited by 29
Ontogeny of haematopoiesis: recent advances and open questions
Ottersbach, K., Smith, A. M., Wood, A., & Göttgens, B. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07953.x · Cited by 35
“…possible, which demonstrated that a large proportion of the genes involved encoded classical DNA-binding transcription factors (e.g. Tal1/Scl, Runx1/Aml1, Etv6/Tel), transcriptional cofactors (e.g. Lmo2, Lmo1) or epigenetic regulators (e.g. Mll, Moz, CBP) (Rabbitts, 1994; Rosenbauer & Tenen, 2007).”
BackgroundTao, J., Li, L., Fu, R., Wang, H., Jiang, H., Yue, L., Zhang, W., Liu, H., Ruan, E.-B., Qü, W., et al. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.03.018 · Cited by 27
Palani, S., & Sarkar, C. A. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000518 · Cited by 32
“1, T-bet, and GATA-3 orchestrate the differentiation program of erythrocytes, neutrophils, Th1, and Th2 cells, respectively, by regulating the expression of their lineage-specific genes [6,38].”
Activation of the Unfolded Protein Response in Human Acute Myeloid Leukemia
Schardt, J., Mueller, B. U., & Pabst, T. (2011) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-385116-1.00013-3 · Cited by 31
The Justy mutation identifies Gon4-like as a gene that is essential for B lymphopoiesis
Lu, P., Hankel, I. L., Knisz, J., Marquardt, A., Chiang, M.-Y., Grosse, J., Constien, R., Meyer, T., Schröeder, A., Zeitlmann, L., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100147 · Cited by 27
“Also, disruption of the hematopoietic transcription factor network is strongly associated with oncogenesis (O’Neil and Look, 2007; Rosenbauer and Tenen, 2007).”
BackgroundJensen, K., Makins, G. D., Kaliszewska, A., Hulme, M. J., Paxton, E. A., & Glass, E. J. (2009) · International Journal for Parasitology · doi:10.1016/j.ijpara.2009.02.020 · Cited by 26
“In contrast, Pu.1 is expressed throughout the differentiation programme, from early progenitor cell to m/ (Rosenbauer and Tenen, 2007).”
BackgroundHigh Tim-3 expression on AML blasts could enhance chemotherapy sensitivity
Xu, L., Xu, J., Ma, S., Li, X., Zhu, M., Chen, S., Han, Y., Tang, X., Fu, Z., Qiu, H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22141 · Cited by 28
“Mutations in core binding transcription factors that regulate myeloid differentiation may directly regulate Tim-3 transcription or arrest leukemic cells in a stage of differentiation associated with high Tim-3 expression [20, 21].”
BackgroundLiu, L., Zhang, J., Zhang, X., Cheng, P., Liu, L., Huang, Q., Liu, H., Ren, S., Wei, P., Wang, C., et al. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01998-5 · Cited by 27
Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling
Sharma, A. K., Yun, H., Jyotsana, N., Chaturvedi, A., Schwarzer, A., Yung, E., Lai, C. K., Kuchenbauer, F. C., Argiropoulos, B., Görlich, K., et al. (2014) · Leukemia · doi:10.1038/leu.2014.162 · Cited by 28
Transcriptional and Microenvironmental Regulation of Lineage Ambiguity in Leukemia
Hu, T., Murdaugh, R. L., & Nakada, D. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00268 · Cited by 32
Zassadowski, F., Pokorná, K., Ferré, N., Guidez, F., Llopis, L., Chourbagi, O., Chopin, M., Poupon, J., Fenaux, P., Padua, R. A., et al. (2015) · Leukemia · doi:10.1038/leu.2015.159 · Cited by 24
Orfali, N. M., O’Donovan, T. R., Cahill, M. R., Benjamin, D., Nanus, D. M., McKenna, S. L., Gudas, L. J., & Mongan, N. P. (2019) · European Journal Of Haematology · doi:10.1111/ejh.13367 · Cited by 25
“1 (SP1 gene) and CEBPe (Figure 1B).(32) The GATA2 transcription factor preserves a stem-like state in hematopoietic cells and is downregulated during differentiation.”
BackgroundmiR‐204 is dysregulated in metastatic prostate cancer in vitro
Todorova, K. O., Metodiev, M. V., Metodieva, G., Zasheva, D., Mincheff, M. S., & Hayrabedyan, S. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22263 · Cited by 26
Noguera, N. I., Piredda, M. L., Taulli, R., Catalano, G., Angelini, G., Gaur, G., Nervi, C., Voso, M. T., Lunardi, A., Pandolfi, P. P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11964 · Cited by 27
“1 in the adult hematopoietic tissue produces dysfunctional stem cells and impairs granulopoiesis, by inducing a maturation block [18].”
BackgroundDecoding sequence determinants of gene expression in diverse cellular and disease states
Lal, A., Karollus, A., Gunsalus, L. M., Garfield, D., Nair, S., Tseng, A. M., Gordon, M. G., Blischak, J., Geijn, B. V. D., Bhangale, T., et al. (2026) · Nature Methods · doi:10.1038/s41592-026-03102-0 · Cited by 37
“3g), and DE attribution scores for genes upregulated in cardiac fibroblasts consistently highlighted motifs for GATA4 and GATA6, which are known signature TFs for cardiac fibroblasts 19,35 , and TEAD1, an essential regulator of cardiac fibroblast activation 36,37 .”
MicroRNA-Regulated Pathways in Hematological Malignancies: How to Avoid Cells Playing Out of Tune
Fatica, A., & Fazi, F. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141020930 · Cited by 25
“normal granulopoiesis that is frequently disrupted in AML [9].”
BackgroundRegulation of the C/EBPα signaling pathway in acute myeloid leukemia (Review)
Song, G., Wang, L., BI, K., & Jiang, G. (2015) · Oncology Reports · doi:10.3892/or.2015.3848 · Cited by 38
“The transcription factor CCAAT/enhancer binding protein α (C/EBPα) is a lineagespecific transcription factor in the hematopoietic system and is required for the formation of committed myeloid progenitors from multipotent precursor cells by coupling the direct transcriptional activation of myeloid-specific genes with t…”
BackgroundCebpα is essential for the embryonic myeloid progenitor and neutrophil maintenance in zebrafish
Dai, Y., Zhu, L., Huang, Z., Zhou, M., Jin, W., Liu, W., Xu, M., Yu, T., Zhang, Y., Wen, Z., et al. (2016) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2016.09.001 · Cited by 24
Metadata
- Authors
- Rosenbauer, F., & Tenen, D. G.
- Affiliations
- Max Delbrück Center (DE)
- Harvard University (US)
- Venue
- Nature Reviews Immunology
- Published
- 2007-02
- Volume
- 7
- Issue
- 2
- Pages
- 105-117
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1980860344
- Cited by
- 606
- References
- 142
- Citations by year
- 2026: 20 · 2025: 20 · 2024: 21 · 2023: 24 · 2022: 29 · 2021: 17 · 2020: 21 · 2019: 28 · 2018: 30 · 2017: 45 · 2016: 31 · 2015: 42 · 2014: 38 · 2013: 43 · 2012: 27
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Funders
- Lymphoma Research Foundation
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- transcription factors, myeloid development, myeloid differentiation, myeloid leukemia, differentiation block, transcription factor dysregulation, cell fate regulation
- MeSH terms
- Animals, Cell Differentiation, Cell Transformation, Neoplastic, Hematopoietic Stem Cells, Humans, Leukemia, Myeloid, Transcription Factors, Mice, Knockout, Cell Lineage, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.